SEC Form 4 · accession 0001415889-18-001103
Medite Cancer Diagnostics, Inc. · MDIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John H Abeles
Director
Period of report
Jul 3, 2018
Accepted (ET)
Jul 10, 2018 · 3:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000075439
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 3, 2018 | P | 400,000 | $0.075 | A | 2,608,381 | I | Northlea Partners, Ltd. |
Table II — derivative securities
No Table II lines on this filing.